We also evaluated somatic alterations in common tumor associated pathways in two subgroups, including RTK-RAS, Hippo, WNT, PI3K, NOTCH, MYC, NRF2, TP53, TGF-Beta, and Cell cycle (28). The gene discussed is TP53; the disease is neoplasm.